Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3443-45-6 | MDL No. : | MFCD00004141 |
Formula : | C20H16O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QXYRRCOJHNZVDJ-UHFFFAOYSA-N |
M.W : | 288.34 | Pubchem ID : | 76977 |
Synonyms : |
|
Num. heavy atoms : | 22 |
Num. arom. heavy atoms : | 16 |
Fraction Csp3 : | 0.15 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 91.3 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.4 cm/s |
Log Po/w (iLOGP) : | 2.55 |
Log Po/w (XLOGP3) : | 5.15 |
Log Po/w (WLOGP) : | 4.99 |
Log Po/w (MLOGP) : | 4.33 |
Log Po/w (SILICOS-IT) : | 5.26 |
Consensus Log Po/w : | 4.46 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -5.15 |
Solubility : | 0.00206 mg/ml ; 0.00000714 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.68 |
Solubility : | 0.000604 mg/ml ; 0.0000021 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -7.17 |
Solubility : | 0.0000197 mg/ml ; 0.0000000684 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | Stage #1: With potassium hydroxide; hydrazine In diethylene glycol for 2 h; Heating / reflux Stage #2: With hydrogenchloride In water; diethylene glycol at 0℃; |
1 g (2.78 mmol) of 4-oxo-4-(pyrene-1-yl)-butyric acid was dissolved in 30 ml diethylene glycol and 0.5 9 (10 mmol) of hydrazine hydrate as well as 0.56 g (10 mmol) of KOH added thereto. The reaction solution was heated under reflux for 2 hours and then poured onto iced hydrochloric acid (25percent), forming a yellow precipitate. Filtration of the solid and recrystallization from EtOH yielded 570 mg (71percent) of 4-(pyrene-1-yl)-butyric acid.M (C20H16O2)=288 g/molEI-MS: m/z (percent)=289 (16) [MH+], 288 (62) [M], 216 (20), 215 (100), 213 (11). HR-EI-MS C20H16O2): calc.: 288.1150; found: 288.1150. 1H-NMR ([D6]-DMSO): δ (ppm)=8.50-7.92 (9H, m, CHarom), 3.36 (2H, m, CH2C16H9), 2.41 (2H, m, CH2CO2H), 2.04 (2H, m, CH2). 1H-NMR (CDCl3): δ (ppm)=8.32-7.86 (9H, m, CHarom), 3.42 (2H, t, CH2C16H9, 3JHH=7.57 Hz), 2.51 (2H, t, CH2CO2H, 3JHH=7.00 Hz), 2.23 (2H, m, CH2, 3JHH=7.57 Hz, 3JHH=7.00 Hz). 13C-NMR ([D6]-DMSO): δ(ppm)=174.74 (1 CO), 136.39-123.39 (9 CHarom, 7 Carom), 33.64-26.98 (1 CH2CO2H, 2 CH2). 13C-NMR (CDCl3): δ (ppm)=177.48 (1 CO), 135.25-123.04 (9 CHarom, 7 Carom), 33.21-26.46 (1 CH2CO2H, 2 CH2). IR (KBr): {tilde over (ν)} (cm-1)=3447w, 3037w, 2950m, 2934w, 2874w, 1695s, 1431w, 1275m, 1206m, 918w, 846s, 711w. |
[ 71367-28-7 ]
3,3'-(Anthracene-9,10-diyl)dipropanoic acid
Similarity: 0.97
[ 35888-99-4 ]
3-([1,1'-Biphenyl]-4-yl)propanoic acid
Similarity: 0.94
[ 71367-28-7 ]
3,3'-(Anthracene-9,10-diyl)dipropanoic acid
Similarity: 0.97
[ 35888-99-4 ]
3-([1,1'-Biphenyl]-4-yl)propanoic acid
Similarity: 0.94